Clinical trial
Phase IV Study on the Safety and Efficacy of Megace Oral Suspension in HIV-Positive Females
NCT00002345 is registered in ClinicalTrials.gov with Bristol-Myers Squibb as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase IV Study on the Safety and Efficacy of Megace Oral Suspension in HIV-Positive Females
- Lead sponsor
- Bristol-Myers Squibb
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- Not reported
- Completion date
- Not reported
- Enrollment
- 40
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.